Quantifying the impact of quarantine duration on COVID-19 transmission

  1. Peter Ashcroft  Is a corresponding author
  2. Sonja Lehtinen
  3. Daniel C Angst
  4. Nicola Low
  5. Sebastian Bonhoeffer  Is a corresponding author
  1. ETH Zurich, Switzerland
  2. University of Bern, Switzerland

Abstract

The large number of individuals placed into quarantine because of possible SARS CoV-2 exposure has high societal and economic costs. There is ongoing debate about the appropriate duration of quarantine, particularly since the fraction of individuals who eventually test positive is perceived as being low. We use empirically determined distributions of incubation period, infectivity, and generation time to quantify how the duration of quarantine affects onward transmission from traced contacts of confirmed SARS-CoV-2 cases and from returning travellers. We also consider the roles of testing followed by release if negative (test-and-release), reinforced hygiene, adherence, and symptoms in calculating quarantine efficacy. We show that there are quarantine strategies based on a test-and-release protocol that, from an epidemiological viewpoint, perform almost as well as a 10 day quarantine, but with fewer person days spent in quarantine. The findings apply to both travellers and contacts, but the specifics depend on the context.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. These files are available on github (https://github.com/ashcroftp/quarantine2020/) and archived at https://doi.org/10.5281/zenodo.4498169.

Article and author information

Author details

  1. Peter Ashcroft

    Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
    For correspondence
    peter.ashcroft@env.ethz.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4067-7692
  2. Sonja Lehtinen

    Department of Environmental Systems Science, ETH Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4236-828X
  3. Daniel C Angst

    Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6512-4595
  4. Nicola Low

    University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Sebastian Bonhoeffer

    Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
    For correspondence
    seb@env.ethz.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8052-3925

Funding

H2020 European Research Council (EpiPose,101003688)

  • Nicola Low

Swiss National Science Foundation (176233)

  • Nicola Low

Swiss National Science Foundation (176401)

  • Sebastian Bonhoeffer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Deborah Cromer, University of New South Wales, Australia

Version history

  1. Received: October 2, 2020
  2. Accepted: February 4, 2021
  3. Accepted Manuscript published: February 5, 2021 (version 1)
  4. Version of Record published: March 16, 2021 (version 2)

Copyright

© 2021, Ashcroft et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 12,068
    Page views
  • 654
    Downloads
  • 51
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Peter Ashcroft
  2. Sonja Lehtinen
  3. Daniel C Angst
  4. Nicola Low
  5. Sebastian Bonhoeffer
(2021)
Quantifying the impact of quarantine duration on COVID-19 transmission
eLife 10:e63704.
https://doi.org/10.7554/eLife.63704

Share this article

https://doi.org/10.7554/eLife.63704

Further reading

    1. Epidemiology and Global Health
    2. Medicine
    3. Microbiology and Infectious Disease
    Edited by Diane M Harper et al.
    Collection

    eLife has published the following articles on SARS-CoV-2 and COVID-19.

    1. Ecology
    2. Epidemiology and Global Health
    Aleksandra Kovacevic, David RM Smith ... Lulla Opatowski
    Research Article

    Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase in antibiotic resistance among invasive Streptococcus pneumoniae isolates from 2019 to 2020, while an increasing number of studies reported stable pneumococcal carriage prevalence over the same period. To disentangle the impacts of the COVID-19 pandemic on pneumococcal epidemiology in the community setting, we propose a mathematical model formalizing simultaneous transmission of SARS-CoV-2 and antibiotic-sensitive and -resistant strains of S. pneumoniae. To test hypotheses underlying these trends five mechanisms were built into the model and examined: (1) a population-wide reduction of antibiotic prescriptions in the community, (2) lockdown effect on pneumococcal transmission, (3) a reduced risk of developing an IPD due to the absence of common respiratory viruses, (4) community azithromycin use in COVID-19 infected individuals, (5) and a longer carriage duration of antibiotic-resistant pneumococcal strains. Among 31 possible pandemic scenarios involving mechanisms individually or in combination, model simulations surprisingly identified only two scenarios that reproduced the reported trends in the general population. They included factors (1), (3), and (4). These scenarios replicated a nearly 50% reduction in annual IPD, and an increase in antibiotic resistance from 20% to 22%, all while maintaining a relatively stable pneumococcal carriage. Exploring further, higher SARS-CoV-2 R0 values and synergistic within-host virus-bacteria interaction mechanisms could have additionally contributed to the observed antibiotic resistance increase. Our work demonstrates the utility of the mathematical modeling approach in unraveling the complex effects of the COVID-19 pandemic responses on AMR dynamics.